Navigation Links
Atkins Diet Tougher on Heart After Weight Loss
Date:4/1/2009

Study found worse cholesterol, blood vessel health than with South Beach, Ornish regimens

WEDNESDAY, April 1 (HealthDay News) -- In the "maintenance" phase that occurs after initial weight loss, the popular Ornish and South Beach diets seem to be easier on the heart than the high-fat, low-carbohydrate Atkins regimen, a new study finds.

Unlike numerous studies that have evaluated diets to see which might be better at achieving weight loss, this study, funded by the U.S. National Institutes of Health, looked at what happens to cholesterol levels and other cardiac risk factors when dieters reach their goal weight and remain on the diet.

The study involved 18 healthy people, with an average body-mass index (BMI) of 22.6 (18.5 to 24.9 is considered normal weight). Participants completed four weeks each on the Atkins (50 percent fat), South Beach (30 percent fat) and Ornish (10 percent fat) diets, in random order and with a four-week "washout" period between each diet. The study was done from January to December 2006.

The switch between diets meant that "each person served as his own control," explained principal investigator Dr. Michael Miller, director of the Center for Preventive Cardiology at the University of Maryland Medical Center in Baltimore.

At the start and after each four-week diet, the researchers evaluated cholesterol levels and other cardiac risk factors. They also looked at three-day food records at the end of each diet phase. And they checked blood vessel functioning by measuring blood vessel dilation in the arm.

They found that "as you increase the amount of saturated fat [in the diet], blood vessel dilation is reduced," Miller said. Healthy vessel dilation is important to proper blood flow.

"The diet that performed the worst [on the blood vessel test] was the Atkins diet," Miller said. "It contains more saturated fat."

Participants ate about 30 grams of satura
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Atkins Responds to Recent New England Journal of Medicine Weight-Loss Diets Study Results
2. Atkins(TM) Nutritionals Products Are Not Affected by FDA Peanut Butter Recall
3. Atkins-Like Diet Cuts Epileptic Seizures
4. Modified Atkins diet can cut epileptic seizures in adults
5. Atkins Diet Can Raise Heart Risks
6. Terror Fears Tougher on Minorities, Disabled
7. Quitting Smoking Tougher on Women
8. FDA Demands Tougher Warnings on Immunosuppressive Drugs
9. Minorities, Poor Have Tougher Time Monitoring Diabetes
10. FDA Panel Backs Tougher Warning on Asthma Drugs for Kids
11. FDA Panel Backs Tougher Warning for Tamiflu
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Atkins Diet Tougher on Heart After Weight Loss
Atkins Diet Tougher on Heart After Weight Loss
Other Medicine Technology:Lixte Biotechnology Holdings Announces Filing of a New Patent Application for the Use of Novel Compounds as Potential Treatment for Neurodegenerative Diseases 2Cell Therapeutics Announces that the European Organization for Research and Treatment of Cancer Completes Enrollment in Phase II Clinical Trial of Brostallicin as First Line Therapy for Advanced or Metastatic Soft Tissue Sarcoma 2Cell Therapeutics Announces that the European Organization for Research and Treatment of Cancer Completes Enrollment in Phase II Clinical Trial of Brostallicin as First Line Therapy for Advanced or Metastatic Soft Tissue Sarcoma 3Cell Therapeutics Announces that the European Organization for Research and Treatment of Cancer Completes Enrollment in Phase II Clinical Trial of Brostallicin as First Line Therapy for Advanced or Metastatic Soft Tissue Sarcoma 4Cell Therapeutics Announces that the European Organization for Research and Treatment of Cancer Completes Enrollment in Phase II Clinical Trial of Brostallicin as First Line Therapy for Advanced or Metastatic Soft Tissue Sarcoma 5Cell Therapeutics Announces that the European Organization for Research and Treatment of Cancer Completes Enrollment in Phase II Clinical Trial of Brostallicin as First Line Therapy for Advanced or Metastatic Soft Tissue Sarcoma 6